Clinical Trial: Clinical Study of Camrelizumab Combined with Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Esophageal Cancer (China)

Posted On: 2026-10-01

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Study of Camrelizumab Combined with Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Esophageal Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133689

Registration Time: 2026/09/30

Type: Observational study

Primary Sponsor: Fuyang Tumour Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339112

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

Clinical Trial: Clinical Study of Camrelizumab Combined with Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Esophageal Cancer (China)